This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Université´ D'aix-Marseille. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019-2020
Title: Fabien Aubry: Innovator in RNA Virus Technology
Introduction
Fabien Aubry is a notable inventor based in Marseille, France. He has made significant contributions to the field of virology, particularly in the rapid generation of RNA viruses. With a total of 2 patents, his work has the potential to advance medical research and therapeutic applications.
Latest Patents
Aubry's latest patents include a "Method for rapid generation of an attenuated RNA virus." This invention utilizes mutagenesis to produce an attenuated RNA virus quickly, as soon as the complete sequence of the target virus is known. His second patent, "Method for rapid generation of an infectious RNA virus," describes a process that eliminates the need for constructing a full-length cDNA that covers the entire viral genome, streamlining the production of infectious RNA viruses.
Career Highlights
Throughout his career, Fabien Aubry has worked with prestigious institutions such as the National Institute of Health and Medical Research and Université d'Aix-Marseille. His research has focused on innovative methods to enhance the efficiency of RNA virus generation, which is crucial for vaccine development and infectious disease research.
Collaborations
Aubry has collaborated with notable scientists in his field, including Xavier De Lamballerie and Ernest Andrew Gould. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Fabien Aubry's contributions to RNA virus technology highlight his role as an innovator in the field of virology. His patents reflect a commitment to advancing scientific knowledge and improving public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile